Reverse transcriptase - PDFSEARCH.IO - Document Search Engine

Reverse transcriptase
Results: 600

#	Item
371	Table 1: 1994 Revised Human Immunodeficiency Virus Pediatric Classification Add to Reading List Source URL: www.cdph.ca.gov Language: English - Date: 2013-01-26 21:50:12 Pharmacology Bristol-Myers Squibb Cyclopropanes Purines Gilead Sciences Antiretroviral drug Reverse-transcriptase inhibitor Nucleoside analogue Emtricitabine Chemistry Organic chemistry Organofluorides
372	CLINICAL REVIEW Application Type NDAs[removed] Add to Reading List Source URL: www.fda.gov Language: English Cyclopropanes Organofluorides Bristol-Myers Squibb Lactams Nevirapine Efavirenz Reverse-transcriptase inhibitor Antiretroviral drug AIDS Clinical Trials Group Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors
373	Isentress (raltegravir) tablets label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-08-06 09:50:44 Gilead Sciences Carbamates Non-nucleoside reverse transcriptase inhibitors Integrase inhibitors Raltegravir Tenofovir Efavirenz Darunavir Antiretroviral drug Chemistry Organic chemistry Organofluorides
374	CLINICAL PHARMACOLOGY REVIEW NDA: [removed]SE5 027 &[removed]SE5 017 Submission Date(s): December 20, 2007 Brand Name Add to Reading List Source URL: www.fda.gov Language: English Non-nucleoside reverse transcriptase inhibitors Amines Drug rehabilitation Lactams Nevirapine Methadone Chemistry Organic chemistry Cyclopropanes
375	Kaletra FDA Presentation Slides Add to Reading List Source URL: www.fda.gov Language: English Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Carbamates Fixed dose combination Lopinavir/ritonavir Lopinavir Antiretroviral drug Efavirenz Nevirapine Chemistry Organic chemistry Protease inhibitors
376	N21449S011 Pediatric Clinical Review Add to Reading List Source URL: www.fda.gov Language: English Clinical research Pharmacology Gilead Sciences Adefovir Entecavir Hepatitis B Reverse-transcriptase inhibitor Clinical trial Placebo Medicine Health Purines
377	VIDEX EC (Didanosine) Clinical Pharmacology Review NDA Submission Date(s) PDUFA Due Date Add to Reading List Source URL: www.fda.gov Language: English Reverse-transcriptase inhibitor AIDS Clinical Trials Group Purines Bristol-Myers Squibb Didanosine
378	Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Add to Reading List Source URL: www.fda.gov Language: English Cyclopropanes Lactams Nevirapine Pyridines Medical prescription Reverse transcriptase Reverse-transcriptase inhibitor Pharmacy Etravirine Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors
379	Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Add to Reading List Source URL: www.fda.gov Language: English Chemistry Organic chemistry Piperazines Reverse-transcriptase inhibitor Hepatitis B Norfloxacin Adverse Event Reporting System Purines Gilead Sciences Adefovir
380	Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Add to Reading List Source URL: www.fda.gov Language: English Medicine Bristol-Myers Squibb Didanosine Cyclopropanes Adverse Event Reporting System Reverse-transcriptase inhibitor Ribavirin Abacavir Antiretroviral drug Purines Pharmacology Pharmaceutical sciences

UPDATE